Lv0
0 积分 2023-07-09 加入
Targeting the HGF/MET axis in cancer: therapeutic promise for natural compounds
16小时前
待确认
NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China
17小时前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
17小时前
已完结
皖公网安备34019202002308
